Anticancer compound and enantiomer separation method useful for synthesizing said compound
US6479513B2 · kind B2 · utility
5Cited by
2References
8Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 17, 2001 |
| Grant date | Nov 12, 2002 |
| Priority date | — |
| Expiry date | Jan 17, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the compound (+)-6-[amino-(6-chloro-pyridin-3-yl)-(3-methyl-3H-imidazol-4-yl)-methyl]-4-(3-chloro-phenyl)-1-cyclopropylmethyl-1H-quinolin-2-one, pharmaceutically acceptable salts and solvates thereof, prodrugs thereof, and to the use of said compound for inhibiting abnormal cell growth, including cancer, in mammals. The invention also relates to methods useful in synthesizing the aforementioned compound.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.